Safety of Co-Administered CHI-554 and Alcohol
NCT05317507 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2025-09-12
Summary
This is a Phase 1, randomized, double-blind study to assess the safety, tolerability, and effects of CHI-554 when co-administered with alcohol.
Conditions
- Healthy Adults
Interventions
- DRUG
-
CBD oil
50 mg
- DRUG
-
CBD oil
100 mg CBD
- DRUG
-
Placebo
Sponsors & Collaborators
-
Auburn University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-09
- Primary Completion
- 2023-03-31
- Completion
- 2023-03-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effects of Cannabidiol in Alcohol Use Disorder
NCT03252756 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Alcohol Use Disorder and Cannabidiol
NCT05613608 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder
NCT06512389 ·Status: RECRUITING ·Phase: PHASE2
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040 ·Status: RECRUITING ·Phase: PHASE1
-
Cannabidiol and Alcohol Use Disorder Phenotypes
NCT07279558 ·Status: RECRUITING ·Phase: PHASE2
-
Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal
NCT04205682 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Cannabidiol on the Driving Ability of Healthy Adults
NCT04590495 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT06446479 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
NCT06686914 ·Status: RECRUITING ·Phase: PHASE1
-
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
NCT07148843 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Cannabidiol as a Treatment for AUD Comorbid With PTSD
NCT03248167 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cannabinoids and Cerebellar-Motor Functioning
NCT01853020 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
NCT05322941 ·Status: COMPLETED ·Phase: PHASE2
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol for Reducing Drinking in Alcohol Use Disorder
NCT05159830 ·Status: RECRUITING ·Phase: PHASE2
-
Interest of tDCS in Help for Supporting Alcohol Abstinence
NCT03287154 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol and Cannabis Concentrate Users
NCT06575751 ·Status: RECRUITING ·Phase: PHASE2
-
Citicoline in Youth Alcohol Use Disorder
NCT05870111 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms
NCT05563350 ·Status: COMPLETED
-
Influence of n-Acetylcysteine Maintenance on Alcohol Effects
NCT03216954 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
NCT02823977 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels
NCT05487404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder
NCT02570763 ·Status: WITHDRAWN ·Phase: NA
-
Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving
NCT05305404 ·Status: UNKNOWN ·Phase: EARLY_PHASE1